ATE78183T1 - Diffusionsmatrix fuer transdermale arzneimittelverabreichung und sie enthaltende vorrichtungen zur transdermalen arzneimittelfreisetzung. - Google Patents

Diffusionsmatrix fuer transdermale arzneimittelverabreichung und sie enthaltende vorrichtungen zur transdermalen arzneimittelfreisetzung.

Info

Publication number
ATE78183T1
ATE78183T1 AT87311308T AT87311308T ATE78183T1 AT E78183 T1 ATE78183 T1 AT E78183T1 AT 87311308 T AT87311308 T AT 87311308T AT 87311308 T AT87311308 T AT 87311308T AT E78183 T1 ATE78183 T1 AT E78183T1
Authority
AT
Austria
Prior art keywords
pharmaceutical delivery
transdermal pharmaceutical
diffusion matrix
devices including
medical grade
Prior art date
Application number
AT87311308T
Other languages
German (de)
English (en)
Inventor
Gary W Cleary
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Application granted granted Critical
Publication of ATE78183T1 publication Critical patent/ATE78183T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
AT87311308T 1986-12-22 1987-12-22 Diffusionsmatrix fuer transdermale arzneimittelverabreichung und sie enthaltende vorrichtungen zur transdermalen arzneimittelfreisetzung. ATE78183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94538986A 1986-12-22 1986-12-22
EP87311308A EP0272918B1 (en) 1986-12-22 1987-12-22 Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same

Publications (1)

Publication Number Publication Date
ATE78183T1 true ATE78183T1 (de) 1992-08-15

Family

ID=25483025

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87311308T ATE78183T1 (de) 1986-12-22 1987-12-22 Diffusionsmatrix fuer transdermale arzneimittelverabreichung und sie enthaltende vorrichtungen zur transdermalen arzneimittelfreisetzung.

Country Status (9)

Country Link
US (1) US4911916A (cg-RX-API-DMAC7.html)
EP (1) EP0272918B1 (cg-RX-API-DMAC7.html)
JP (1) JPH07112972B2 (cg-RX-API-DMAC7.html)
AT (1) ATE78183T1 (cg-RX-API-DMAC7.html)
AU (1) AU607172B2 (cg-RX-API-DMAC7.html)
CA (1) CA1308655C (cg-RX-API-DMAC7.html)
DE (1) DE3780432T2 (cg-RX-API-DMAC7.html)
ES (1) ES2041238T3 (cg-RX-API-DMAC7.html)
GR (1) GR3005368T3 (cg-RX-API-DMAC7.html)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468316A (en) * 1987-09-08 1989-03-14 Teikoku Seiyaku Kk External plaster containing salbutamol
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
EP0425505B1 (en) * 1988-06-30 1993-03-17 The Upjohn Company Transdermal antisecretory agents for gastrointestinal disease
FR2635979B1 (fr) * 1988-09-07 1992-05-29 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
DE3838061A1 (de) * 1988-11-10 1990-05-23 Holzer Walter Sterile selbstklebefolie fuer die medizinische eingriffsvorbereitung
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
US5248295A (en) * 1989-05-08 1993-09-28 Iomed, Inc. Bioelectrode seal
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
DE3928858A1 (de) * 1989-08-31 1991-03-07 Beiersdorf Ag Vernetzte hydrogele und verfahren zu deren herstellung
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
JP2839164B2 (ja) * 1989-12-25 1998-12-16 帝國製薬株式会社 消炎鎮痛貼付剤
ES2099747T3 (es) * 1990-06-01 1997-06-01 Population Council Inc Aplicacion topica terapeuticamente eficaz de la st1435.
US5071704A (en) * 1990-06-13 1991-12-10 Fischel Ghodsian Fariba Device for controlled release of vapors and scents
US5455043A (en) * 1990-06-13 1995-10-03 Fischel-Ghodsian; Fariba Device for controlled release of vaporous medications through nasal route
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
JPH06507416A (ja) * 1991-05-07 1994-08-25 ダイナジェン・インコーポレーテッド 禁煙のための調節された持続的放出伝達システム
US5403595A (en) * 1991-05-07 1995-04-04 Dynagen, Inc. Controlled, sustained release delivery system for smoking cessation
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
US5402777A (en) * 1991-06-28 1995-04-04 Alza Corporation Methods and devices for facilitated non-invasive oxygen monitoring
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
RU2120328C1 (ru) * 1992-11-19 1998-10-20 Василий Петрович Афанасьев Способ очистки газовых выбросов и устройство для его осуществления
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
DE4308649C2 (de) * 1993-03-18 1995-11-16 Lohmann Gmbh & Co Kg Medizinisches Pflastermaterial sowie Verfahren zu seiner Herstellung und dessen Verwendung
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5716621A (en) * 1996-07-03 1998-02-10 Pharmadyn, Inc. Nonocclusive drug delivery device and process for its manufacture
US6348210B1 (en) * 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
US7608640B2 (en) * 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
HK1043317B (en) * 1999-04-01 2006-02-10 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
US6277401B1 (en) * 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
US6495229B1 (en) * 1999-09-17 2002-12-17 Avery Dennison Corporation Pattern coated adhesive article
GB2355014A (en) * 1999-10-05 2001-04-11 Procter & Gamble Foams and compositions containing these foams
DE10007859A1 (de) * 2000-02-21 2001-08-23 Bayer Ag Langzeitstabile wasser- und ölabweisende Oberfläche
KR100382373B1 (ko) * 2000-08-28 2003-05-01 주식회사 동성화학 약제의 역확산 억제능이 우수한 패취제 제조용 폴리우레탄 지지체 및 이의 제조방법
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
FR2814949B1 (fr) * 2000-10-11 2004-03-05 Epitact Bille d'orteil pour la prevention ou le soin des effets de l'hyperhydrose plantaire
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
JP5354763B2 (ja) * 2001-03-16 2013-11-27 アルザ・コーポレーシヨン フェンタニルを投与するための経皮的張り付け剤
JP2004537516A (ja) * 2001-05-11 2004-12-16 オラセンス リミテッド アンチセンス浸透促進剤
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
BE1015608A6 (fr) * 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
DE602004003577T2 (de) * 2003-04-17 2007-09-20 Jallal Messadek Flottierende orale Formulierungen mit kontrollierter Freisetzung von Betain
WO2004112724A2 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating hiv
US20080131493A1 (en) * 2004-01-02 2008-06-05 Haitham Matloub Method and Multilayered Device for Controlled Topical Delivery of Therapeutic Agents to the Skin
US8591940B2 (en) * 2004-01-02 2013-11-26 New Medical Technology Inc. Method of treating scar tissue
GB2410748A (en) * 2004-02-03 2005-08-10 Johnson & Johnson Medical Ltd Medicated polyurethane foams
US8219168B2 (en) 2004-04-13 2012-07-10 Abbott Diabetes Care Inc. Article and method for applying a coupling agent for a non-invasive optical probe
JP4557596B2 (ja) * 2004-04-28 2010-10-06 積水化成品工業株式会社 外用貼付剤およびその製造方法、並びにその使用方法
BE1016128A6 (fr) * 2004-07-22 2006-03-07 Messadek Jallal Combinaisons therapeutiques
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US7833979B2 (en) * 2005-04-22 2010-11-16 Amgen Inc. Toxin peptide therapeutic agents
ATE540690T1 (de) * 2005-04-27 2012-01-15 Jallal Messadek Insulinkombinationen
US7469437B2 (en) 2005-06-24 2008-12-30 Tempur-Pedic Management, Inc. Reticulated material body support and method
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
CN1994290B (zh) * 2006-01-04 2011-03-16 上海医药工业研究院 卡巴拉汀透皮贴剂及其制备方法
DE102006028987A1 (de) * 2006-06-24 2007-12-27 Lts Lohmann Therapie-Systeme Ag Ultraschallverstärktes transdermales therapeutisches System
WO2008008281A2 (en) * 2006-07-07 2008-01-17 Proteus Biomedical, Inc. Smart parenteral administration system
AU2007343796A1 (en) 2006-10-25 2008-07-24 Amgen Inc. Toxin peptide therapeutic agents
CL2008000512A1 (es) 2007-02-22 2008-08-29 Bayer Cropscience Sa Compuestos derivados de n-(3-fenilpropil)carboxamida; procedimiento de preparacion de dichos compuestos; composicion fungicida; y metodo para combatir de forma preventiva o curativa los hongos fitopatogenos de cultivos.
AU2008262490B2 (en) 2007-05-22 2011-11-17 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
CN104398496B (zh) * 2007-10-15 2018-03-20 阿尔扎公司 芬太尼的一天更换一次透皮施用
JP5243548B2 (ja) * 2007-10-25 2013-07-24 プロテウス デジタル ヘルス， インコーポレイテッド 情報システムのための流体伝達ポート
WO2009067463A1 (en) * 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
WO2009065193A1 (en) * 2007-11-21 2009-05-28 Jallal Messadek Treatment of aspirin resistance with betaine and/or betaine enriched molasses
US20100100060A1 (en) * 2008-10-17 2010-04-22 Novartis Ag Applicator for pharmaceutical product and method of using same
KR101325104B1 (ko) * 2009-09-16 2013-11-07 주식회사 삼양바이오팜 경피 투여 제형 및 그 제조 방법
WO2011094606A2 (en) 2010-02-01 2011-08-04 Proteus Biomedical, Inc. Data gathering system
SG10201503428RA (en) 2010-02-01 2015-06-29 Proteus Digital Health Inc Data Gathering System
US11607407B2 (en) 2010-04-13 2023-03-21 Relmada Therapeutics, Inc. Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use
HK1198173A1 (en) 2011-03-16 2015-03-13 Amgen Inc. Potent and selective inhibitors of nav1.3 and nav1.7
TW201446792A (zh) 2013-03-12 2014-12-16 Amgen Inc Nav1．7之強效及選擇性抑制劑
KR20190122205A (ko) 2016-12-29 2019-10-29 퓨어 래티오스 홀딩스, 인크. 모듈식 경피 전달 시스템, 및 관련 제조 및 사용 방법
US11318190B2 (en) 2017-05-05 2022-05-03 United States Government As Represented By The Department Of Veterans Affairs Methods and compositions for treating liver disease

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426754A (en) * 1964-06-12 1969-02-11 Celanese Corp Breathable medical dressing
US3486968A (en) * 1967-10-12 1969-12-30 Reeves Bros Inc Microporous polyurethane coatings and films
NO134790C (no) * 1968-07-09 1984-03-22 Smith & Nephew Klebende,; trykkfoelsomt, vanndamp-permeabelt produkt for bruk paa hud hos mennesker.
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
US3685734A (en) * 1971-02-19 1972-08-22 Minnesota Mining & Mfg Controlled fragrance release device
US3849238A (en) * 1972-04-07 1974-11-19 S Ronel Artificial skin
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
IE51473B1 (en) * 1980-08-13 1986-12-24 Smith & Nephew Ass Polymer blend films,their preparation and use
DK147035C (da) * 1980-12-05 1984-09-03 Coloplast As Hudplade
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4460372A (en) * 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4453007A (en) * 1981-11-23 1984-06-05 Usv Pharmaceutical Corporation Method for increasing the purity of amphoteric compound compositions
US4460371A (en) * 1981-11-24 1984-07-17 Dennison Manufacturing Company Silicone pressure sensitive adhesive and uses
US4510197A (en) * 1983-04-01 1985-04-09 The Kendall Company Water vapor permeable pressure sensitive adhesives incorporating modified acrylate copolymers
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
EP0190262B1 (en) * 1984-07-24 1990-12-27 Key Pharmaceuticals, Inc. Adhesive transdermal dosage layer
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
US4559054A (en) * 1984-08-09 1985-12-17 Research Corporation Rate-controlled drug release system
US4600001A (en) * 1984-08-15 1986-07-15 The Kendall Company Combined wound dressing and delivery means composite
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
EP0196769B1 (en) * 1985-02-25 1992-07-08 Rutgers, The State University of New Jersey A novel transdermal pharmaceutical absorption dosage unit
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4638797A (en) * 1986-04-23 1987-01-27 Acme United Corporation Reinforced moisture vapor permeable, pressure-sensitive adhesive wound dressings
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers

Also Published As

Publication number Publication date
CA1308655C (en) 1992-10-13
US4911916A (en) 1990-03-27
ES2041238T1 (es) 1993-11-16
EP0272918A3 (en) 1988-08-24
EP0272918A2 (en) 1988-06-29
AU607172B2 (en) 1991-02-28
EP0272918B1 (en) 1992-07-15
DE3780432D1 (de) 1992-08-20
GR3005368T3 (cg-RX-API-DMAC7.html) 1993-05-24
JPH07112972B2 (ja) 1995-12-06
ES2041238T3 (es) 1994-01-16
DE3780432T2 (de) 1992-12-10
JPS63190823A (ja) 1988-08-08
AU8249987A (en) 1988-06-23

Similar Documents

Publication Publication Date Title
ATE78183T1 (de) Diffusionsmatrix fuer transdermale arzneimittelverabreichung und sie enthaltende vorrichtungen zur transdermalen arzneimittelfreisetzung.
NO904317D0 (no) Laminert sammensetning for transdermal administrering av fentanyl.
NZ220016A (en) Transdermal drug delivery system with drug reservoir(s), adhesive layer(s) and flexible backing layer
PT86426A (pt) Dispositivo resiliente para a administracao de um medicamento por via transdermica, e dispositivos empregando esteres/eteres de acidos gordos de alcanodiois como estimuladores da absorcao percutanea
ATE77962T1 (de) Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
DE69414502D1 (de) Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen
EP0290482A4 (en) Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
FI880409A0 (fi) Transdermalt absorberande doseringsenhet foer estradiol och andra estrogena steroider och administrationsfoerfarande.
ATE5563T1 (de) Therapeutisches system zum zufuehren von arzneimitteln zur haut.
DE69531488D1 (de) Medikament enthaltende, adhesive, zusammenbaubare, transdermale abgabevorrichtung
KR870006906A (ko) 피부투과식 약물투여장치
NL970007I1 (nl) Transdermaal oestradiotoedieningssysteem.
NL190508B (nl) Preparaat geschikt voor gebruik als matrix in een systeem voor het toedienen van een geneesmiddel, alsmede een transdermaal therapeutisch systeem, dat het preparaat omvat.
DE59006461D1 (de) Therapeutisches System zur verzögerten und gesteuerten transdermalen oder transmucosalen Verabreichung von Wirkstoffen (II).
DK109689A (da) Praeparater med forbedret penetration
EP0664119A3 (en) Tape transdermal use easily detachable from the skin
CA2183960C (en) MEDICAL STAMPS FOR PERCUTANEOUS ADMINISTRATION
GB2269099A (en) Percutaneous anaesthesia
ATE94769T1 (de) Transdermales abgabesystem fuer procaterol.
NO952908L (no) Nitroglycerolholdig plaster, fremgangsmåte for fremstilling, samt anvendelse av plasteret
AU6229086A (en) Novel transdermal anti-anginal pharmaceutical dosage unit and process for its administration
Hogan et al. Transdermal drug delivery systems: An academic view.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee